The Biotech Event Accelerating Fresh Ideas, Partnerships and Opportunities
Be a part of this unique experience spanning the drug development value chain, giving you access to the most innovative scientific minds and business leaders in Boston and around the world.
Covering Cutting-Edge Scientific and Business Trends in Drug Delivery
Pharma, biotech and drug delivery industries will gather at the 14th annual PODD event to assess delivery needs, information...
Partnership Opportunities in Drug Delivery Editor interviews Jarlath Keating, CEO of Phoshorex . Article entitled "CDMO Innovations to Facilitate New Therapeutics Development"
Webinar featuring our Formulation Scientist, Sydney Marchando, MS. & Nick Boylan, Ph.D., Director of Nucleic Acid Delivery.
Glioblastoma (GBM) is a malignant brain tumor that remains among the most formidable cancers.Despite a well-established standard of care of maximal surgical resection followed by radiotherapy plus concomitant temozolomide (TMZ), median survival remains approximately 15 months.
Our team presents the process of Nanosuspension for the novel Indirubin, for the potential treatment of Glioblastoma.
Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptid
Phosphorex's director of nucleic delivery presents on Nanoparticles for the delivery of ASO to the CNS
In collaboration with Brown University, Phosphorex presents on the use the nanoparticle formulation, to enable Systematic Delivery of Tx Agent to treat GBM